Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-21

FDA Approved: NATAZIA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NATAZIA, a combined oral contraceptive containing estradiol valerate and estradiol valerate/dienogest, from Baye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NATAZIA (Estradiol valerate and estradiol valerate/dienogest)

Snippet

SUPPL AP for NATAZIA (ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST)